Simeon George Discloses 9.3% Stake in ADARx Pharmaceuticals
Simeon George, M.D., who controls SR One Capital Management, has disclosed a 9.3% stake in ADARx Pharmaceuticals, Inc. common stock. The filing, accepted on October 5, 2026, includes shares converted from preferred stock and IPO purchases, following ADARx's IPO closing on September 28, 2026.